CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +35,000 | 35,000 | ||
| 2026-06-04 | Collins Helen Louise Director | Grant or award · Option to purchase common stock | +35,000 | 35,000 | ||
| 2026-06-04 | SCHAFER CAROL Director | Grant or award · Option to purchase common stock | +35,000 | 35,000 | ||
| 2026-06-04 | Szela Mary T Director | Grant or award · Option to purchase common stock | +35,000 | 35,000 | ||
| 2026-06-04 | Malley Thomas Director | Grant or award · Option to purchase common stock | +35,000 | 35,000 | ||
| 2026-05-21 | Powl Brian T. Chief Commercial Officer | Sale 10b5-1 | −10,000 | $11.00 | $110K | 173,614 |
| 2026-05-19 | FORD KATHLEEN Chief Operating Officer | Sale 10b5-1 | −2,257 | $9.08 | $20K | 153,560 |
| 2026-05-19 | Powl Brian T. Chief Commercial Officer | Sale 10b5-1 | −339 | $9.21 | $3K | 183,614 |
| 2026-05-18 | Bair Teresa Brophy Chief Legal Officer | Sale 10b5-1 | −2,256 | $9.38 | $21K | 226,931 |
| 2026-03-23 | WILSON TROY EDWARD President and CEO | Option exercise | +6,103 | $6.15 | $38K | 435,456 |
| 2026-03-23 | WILSON TROY EDWARD President and CEO | Option exercise · Stock Option (Right to Buy) | +6,103 | 0 | ||
| 2026-03-18 | Malley Thomas Director | Option exercise | +10,000 | $3.12 | $31K | 10,000 |
| 2026-03-18 | Malley Thomas Director | Option exercise · Stock Option (Right to Buy) | +10,000 | 0 | ||
| 2026-01-27 | Burrows Francis Chief Scientific Officer | Sale | −1,311 | $8.46 | $11K | 32,424 |
| 2026-01-27 | Powl Brian T. Chief Commercial Officer | Sale | −4,842 | $8.46 | $41K | 184,847 |
| 2026-01-27 | Powl Brian T. Chief Commercial Officer | Sale | −1,572 | $8.46 | $13K | 183,275 |
| 2026-01-27 | FORD KATHLEEN Chief Operating Officer | Sale | −1,813 | $8.46 | $15K | 153,560 |
| 2026-01-27 | Leoni Mollie Chief Medical Officer | Sale | −3,655 | $8.46 | $31K | 271,799 |
| 2026-01-27 | Leoni Mollie Chief Medical Officer | Sale | −2,233 | $8.46 | $19K | 269,566 |
| 2026-01-27 | Leoni Mollie Chief Medical Officer | Sale | −951 | $8.46 | $8K | 268,615 |
Page 2 of 9 · 164 trades